World Health Organization – Page 49 – Communicable Diseases Research

Post-COVID-19 pulmonary fibrosis and its predictive factors: a prospective study

Research

Published on 2021-10-052022-10-31
Journal: The Egyptian Journal of Radiology and Nuclear Medicine [Category] COVID-19,

Evaluation of the Strategies to Control COVID-19 Pandemic in Four European Countries

Observational Study

Published on 2021-10-052022-10-04
Journal: Frontiers in Public Health [Category] MERS, SARS, 임상,

Early epidemiological investigations: World Health Organization UNITY protocols provide a standardized and timely international investigation framework during the COVID‐19 pandemic

Original Article

Published on 2021-10-052022-10-30
Journal: Influenza and Other Respiratory Viruses [Category] COVID-19, MERS, SARS,

COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness

Research Article

Published on 2021-10-042022-10-29
Journal: PLoS Medicine [Category] COVID-19, MERS,

[키워드] age Analysis approach approximations article available data benefit China Combination compartmental model condition country COVAX COVID-19 COVID-19 case COVID-19 vaccination death deaths disease distribution driver Efficacy eligible epidemiological Essential workers evaluated Evidence Factor group Guidance Health health system healthcare high-risk population hospitalisation Impact implementation increase India Infection infection rate information International investigated Isolation less majority Mortality Multiple nonpharmaceutical intervention NPI NPIs Older Older age Other outcome outcomes pandemic parameter Pearson Perspective Population populations Prevent Preventing Probability question recommendation reduce reduction reported researcher resource returned risk Safe Sensitivity analyses severe disease social contact symptomatic disease the vaccine Transmission Transmission model vaccination Vaccine vaccine availability vaccine dose World Health Organization
[DOI] 10.1371/journal.pmed.1003815 PMC 바로가기 [Article Type] Research Article

A Case Report of a Patient on Therapeutic Warfarin Who Died of COVID-19 Infection with a Sudden Rise in D-Dimer

Case Report

Published on 2021-10-032022-10-28
Journal: Biomedicines [Category] COVID-19,

[키워드] ACE2 acute respiratory syndrome Admission African American angiotensin-converting enzyme 2 Anti-inflammatory Anticoagulant anticoagulation Antiviral benefit binding caused cell membrane clinical manifestations Coagulation system Coagulopathy complex Complication Corona coronavirus COVID 19 COVID-19 Cytokine storm D-dimer value death derivative derivatives global pandemic heparin host cells immunomodulatory indicate Infection Inflammatory response inhibit microbial moderate obese offer outcome pathophysiology Patient patients receptor report Research SARS-CoV-2 Severe case sudden therapeutic unique Warfarin while WHO World Health Organization
[DOI] 10.3390/biomedicines9101382 PMC 바로가기 [Article Type] Case Report

Mental health status and quality of life in close contacts of COVID-19 patients in the post-COVID-19 era: a comparative study

코로나19 이후 시대 코로나19 환자 밀접접촉자의 정신건강상태와 삶의 질: 비교연구

Article

Published on 2021-10-022022-09-10
Journal: Translational Psychiatry [Category] MERS, SARS, 치료기술,

[키워드] age Analysis Analysis of covariance checklist close contact Contact covariance COVID-19 COVID-19 patient cross-sectional cross-sectional study demographic demographic data Depression depressive Depressive symptoms determine distress Early detection Effect Effects examined fatigue group groups Health Organization Health status independent Intervention life long-lasting media mental health multiple logistic regression no significant differences Perception performed PHQ-9 Post-traumatic stress disorder post-traumatic stress symptom Post-traumatic stress symptoms provided Psychiatric disorders Quality Quality of life reported Scientific community severe depression significant difference significantly significantly more traumatic stress symptoms was used were assessed with COVID-19 World Health Organization
[DOI] 10.1038/s41398-021-01623-0 PMC 바로가기 [Article Type] Article

Annexin A1 as a potential prognostic biomarker for COVID-19 disease: Case-control study

COVID-19 질병에 대한 잠재적인 예후 바이오마커로서의 Annexin A1: 사례 대조 연구

Article

Published on 2021-10-012022-09-11
Journal: International journal of clinical practice [Category] MERS, 바이오마커,

[키워드] 95% CI Admission Analysis Annexin annexin A1 ANXA1 AUC Biomarker Blood blood sample Blood samples calculated case-control study characteristic conducted contribute control group COVID-19 COVID-19 disease COVID-19 patient COVID-19 pneumonia cut-off Cytokines determine diagnosis of COVID-19 disease emergency department enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay evaluated group Health Organization healthy volunteer hospital Hospital admission ICU ICU treatment Inflammation intensive care intensive care unit Isolation Mild moderate moderate disease neutrophil participated Patient patients with COVID-19 Pneumonia pro-inflammatory cytokines prognostic biomarker Protein receiver receiver operating characteristic serum significantly lower suppression training Treatment were measured World Health Organization
[DOI] 10.1111/ijcp.14606 PMC 바로가기 [Article Type] Article

Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study

Online Only Articles

Published on 2021-10-012022-10-31
Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID-19, MERS, SARS,

[키워드] 95% CI 95% confidence interval acquisition adjusted hazard ratio age Analysis Antiretroviral therapy association C-reactive protein CCP Characteristics characterization clinical Comorbidities coronavirus disease COVID-19 Cox regression cumulative defined disease severity excluded group higher risk HIV HIV infection HIV-negative hospital Hospitalized Human Human immunodeficiency virus hypoxia increased mortality increased risk ISARIC Kaplan-Meier method Lymphocyte count median modulate Mortality other variable outcome Oxygen therapy patients patients hospitalized people with HIV Prospective respiratory Result SARS-CoV-2 Sex systemic symptom United Kingdom WHO with COVID-19 World Health Organization
[DOI] 10.1093/cid/ciaa1605 PMC 바로가기 [Article Type] Online Only Articles

Environmental and health impacts of spraying COVID-19 disinfectants with associated challenges

Novel Corona Virus (COVID-19) in Environmental Engineering Perspective

Published on 2021-10-012022-10-31
Journal: Environmental science and pollution research inter [Category] COVID-19, COVID19(2023년), MERS, SARS,

[키워드] “COVID-19 acute respiratory syndrome addition agency Anxiety approach be worn carried caused Chemicals Committee concentrations conditions coronavirus coronavirus disease country COVID-19 crown detrimental disease spread disinfectant Environmental pollution global pandemic group Health health impacts Impact international public health Microscope morphology mutagenic outbreak pandemic Panic pathogen Personal protective equipment PHEIC Pollution and COVID-19 Precaution Prevent reported robust Safe SARS-CoV-2 spike spread of COVID-19 the WHO USA Ventilation virus viruses water bodies widespread World Health Organization Wuhan, China
[DOI] 10.1007/s11356-021-16575-7 PMC 바로가기 [Article Type] Novel Corona Virus (COVID-19) in Environmental Engineering Perspective

Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics

백신을 넘어: COVID-19 예상 치료제의 임상 상태

Review

Published on 2021-10-012022-09-11
Journal: Frontiers in Immunology [Category] MERS, SARS, 변종, 신약개발, 진단, 치료제,

[키워드] accelerate addition Antiviral antivirals approach approaches approval approved drug Biology biology of SARS-CoV-2 candidate Candidates caused clinical Clinical course clinical status Clinical studies clinical study contribute country COVID-19 death demonstrated develop Dexamethasone distribution Efficiency Emergency Health Organization identify Immune escape immunization immunomodulators infected individual infected individuals Infection information interferons lab Long COVID long term Neutralizing antibodies New new infections nucleoside pandemic Patient polymerase problem Prospective protective effect reached Remdesivir reported Research SARS-CoV-2 SARS-CoV-2 pandemic SARS-CoV-2 variant SARS-CoV-2 variants severe COVID-19 status Symptom the SARS-CoV-2 the vaccine the vaccines therapeutic Therapeutic benefit therapeutic benefits Therapeutic treatment Therapeutics today translation Treatment Treatment strategies treatment strategy vaccination rates Vaccine Viral World Health Organization world population
[DOI] 10.3389/fimmu.2021.752227 PMC 바로가기 [Article Type] Review